Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure there is an adequate supply of (a) donated blood and (b) blood products.

NHS Blood and Transplant (NHSBT) is responsible for the collection, manufacture, and supply of blood and blood products to National Health Service hospitals.

The Department provided seed funding in 2023 to support NHSBT to increase its collection capacity. New donor centres will open in Brixton and Brighton in 2025 to increase and diversify the donor base.

Since July 2024, NHSBT has been responding to an Amber Alert for O group blood. NHSBT is now meeting the demand for blood and blood products, thanks to increased donations and better management of stock.

With respect to blood products, the Department, in conjunction with NHSBT and NHS England, has led a programme to increase self-sufficiency and resilience in life-saving plasma-based medicines, in response to the lifting of the ban on United Kingdom donor plasma in 2021. The first of these medicines will be given to NHS patients in early 2025.

NHSBT runs campaigns throughout the year, partners with trusted brands, and funds community groups to promote both donation of blood and blood products, stem cells, and organs.